A previous diagnosis of a mental health disorder may predict neuropsychiatric complications in children with systemic lupus ...

Please provide your email address to receive an email when new articles are posted on . Patients with pediatric discoid lupus erythematosus combined with systemic lupus erythematosus were most likely ...

The U.S. Food & Drug Administration (FDA) has granted approval for a novel and less invasive belimumab (Benlysta®) treatment for children with systemic lupus erythematosus (SLE) ages five years and ...

The 200-mg subcutaneous injection is for children 5 years and older. HealthDay News — The US Food and Drug Administration has approved a 200 mg subcutaneous route of administration of Benlysta ...

Detailed mapping of CD4⁺ T cells from children with systemic lupus erythematosus (SLE) has revealed distinct immune cell ...

Several years of preliminary research results suggest chimeric antigen receptor (CAR) T-cell therapy could benefit pediatric patients with refractory systemic lupus erythematosus (SLE). When diagnosed ...

The ACR issued a 2025 guideline for the treatment of SLE that addressed treatment and management of specific organ system ...

In this retrospective analysis, responses persisted with hydroxychloroquine treatment. Results of a study suggest treatment using hydroxychloroquine (HCQ) for immune thrombocytopenia (ITP) related to ...

The findings mean it may be feasible to use adult systemic lupus nephritis (SLE) trial data to reduce the data needed for pediatric indications. Efficacy data from trials of adults with systemic lupus ...